{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:40:44Z","timestamp":1790372444029,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jsbmb.2020.105775","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T03:44:58Z","timestamp":1603856698000},"page":"105775","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls"],"prefix":"10.1016","volume":"205","author":[{"given":"Xiaofen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3526-7111","authenticated-orcid":false,"given":"Ziyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenrui","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7761-3145","authenticated-orcid":false,"given":"Ji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quancheng","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9935","key":"10.1016\/j.jsbmb.2020.105775_bib0005","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jsbmb.2020.105775_bib0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.jsbmb.2020.105775_bib0015","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.jsbmb.2020.105775_bib0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.jsbmb.2020.105775_bib0025","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3390\/cancers11081181","article-title":"Unravelling the diagnostic dilemma: a MicroRNA panel of circulating MiR-16 and MiR-877 as a diagnostic classifier for distal bile duct tumors","volume":"11","author":"Meijer","year":"2019","journal-title":"Cancers (Basel)."},{"issue":"2","key":"10.1016\/j.jsbmb.2020.105775_bib0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3748\/wjg.v17.i2.249","article-title":"Risk factors for hilar cholangiocarcinoma: a case-control study in China","volume":"17","author":"Cai","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.jsbmb.2020.105775_bib0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1478-3231.2009.02149.x","article-title":"Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China","volume":"30","author":"Tao","year":"2010","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.jsbmb.2020.105775_bib0040","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/djz166","article-title":"Prediagnostic plasma bile acid levels and Colon Cancer risk: a prospective study","volume":"112","author":"K\u00fchn","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.jsbmb.2020.105775_bib0045","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","article-title":"FXR regulates intestinal Cancer stem cell proliferation","volume":"176","author":"Fu","year":"2019","journal-title":"Cell"},{"issue":"6391","key":"10.1016\/j.jsbmb.2020.105775_bib0050","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jsbmb.2020.105775_bib0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.jsbmb.2020.105775_bib0060","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.apsb.2015.01.009","article-title":"Bile acid signaling and biliary functions","volume":"5","author":"Jones","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.jsbmb.2020.105775_bib0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","article-title":"Role of bile acids in metabolic control","volume":"29","author":"Molinaro","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.jsbmb.2020.105775_bib0070","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Chavez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jsbmb.2020.105775_bib0075","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.28991","article-title":"New therapeutic concepts in bile acid transport and signaling for management of cholestasis","volume":"65","author":"Trauner","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jsbmb.2020.105775_bib0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/07357907.2012.762781","article-title":"Bile acids affect the growth of human cholangiocarcinoma via NF-kB pathway","volume":"31","author":"Dai","year":"2013","journal-title":"Cancer Invest."},{"issue":"3","key":"10.1016\/j.jsbmb.2020.105775_bib0085","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.27085","article-title":"Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2","volume":"60","author":"Liu","year":"2014","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jsbmb.2020.105775_bib0090","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","article-title":"TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro","volume":"65","author":"Reich","year":"2016","journal-title":"Gut"},{"issue":"Suppl","key":"10.1016\/j.jsbmb.2020.105775_bib0095","first-page":"77","article-title":"Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma","volume":"13","author":"Jusakul","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"17","key":"10.1016\/j.jsbmb.2020.105775_bib0100","doi-asserted-by":"crossref","first-page":"333","DOI":"10.21037\/atm.2018.07.16","article-title":"Current and future roles of mucins in cholangiocarcinoma-recent evidences for a possible interplay with bile acids","volume":"6","author":"Danese","year":"2018","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.jsbmb.2020.105775_bib0105","doi-asserted-by":"crossref","first-page":"11088","DOI":"10.1038\/s41598-018-29445-z","article-title":"Discovery of glycocholic acid and taurochenodeoxycholic acid as phenotypic biomarkers in cholangiocarcinoma","volume":"8","author":"Song","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jsbmb.2020.105775_bib0110","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.7314\/APJCP.2015.16.4.1367","article-title":"Total serum bile acid as a potential marker for the diagnosis of cholangiocarcinoma without jaundice","volume":"16","author":"Sombattheera","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.jsbmb.2020.105775_bib0115","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.3892\/ol.2017.6763","article-title":"Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma","volume":"14","author":"Proungvitaya","year":"2017","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.jsbmb.2020.105775_bib0120","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/hep.30852","article-title":"Characterization of gut microbiota, bile acid metabolism, and cytokines in Intrahepatic Cholangiocarcinoma","volume":"71","author":"Jia","year":"2020","journal-title":"Hepatology (Baltimore, Md.)."},{"key":"10.1016\/j.jsbmb.2020.105775_bib0125","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jsbmb.2017.05.015","article-title":"Quantitative profiling of 19 bile acids in rat plasma, liver, bile and different intestinal section contents to investigate bile acid homeostasis and the application of temporal variation of endogenous bile acids","volume":"172","author":"Yang","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"28","key":"10.1016\/j.jsbmb.2020.105775_bib0130","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/j.jchromb.2010.08.045","article-title":"Quantification of the 15 major human bile acids and their precursor 7alpha-hydroxy-4-cholesten-3-one in serum by liquid chromatography-tandem mass spectrometry","volume":"878","author":"Steiner","year":"2010","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"issue":"12","key":"10.1016\/j.jsbmb.2020.105775_bib0135","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/tx800225q","article-title":"Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry","volume":"21","author":"Yang","year":"2008","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jsbmb.2020.105775_bib0140","series-title":"Bioanalytical Method Validation Guidance for Industry","author":"D. US FDA","year":"2018"},{"issue":"2","key":"10.1016\/j.jsbmb.2020.105775_bib0145","first-page":"81","article-title":"Serum unconjugated primary and secondary bile acids in patients with cholangiocarcinoma and hepatocellular carcinoma","volume":"73","author":"Changbumrung","year":"1990","journal-title":"J. Med. Assoc. Thai."},{"issue":"6","key":"10.1016\/j.jsbmb.2020.105775_bib0150","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1477-2574.2010.00185.x","article-title":"Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy","volume":"12","author":"Sharif","year":"2010","journal-title":"HPB"},{"issue":"6","key":"10.1016\/j.jsbmb.2020.105775_bib0155","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1477-2574.2011.00296.x","article-title":"Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma","volume":"13","author":"Hashim Abdalla","year":"2011","journal-title":"HPB"},{"issue":"5","key":"10.1016\/j.jsbmb.2020.105775_bib0160","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.cell.2019.01.036","article-title":"FXR regulates intestinal Cancer stem cell proliferation","volume":"176","author":"Fu","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jsbmb.2020.105775_bib0165","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/jnci\/djz166","article-title":"Pre-diagnostic plasma bile acid levels and colon cancer risk: a prospective study","volume":"112","author":"Kuhn","year":"2020","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2020.105775_bib0170","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","article-title":"Bile acid metabolism and signaling in Cholestasis, inflammation, and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.jsbmb.2020.105775_bib0175","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.jsbmb.2020.105775_bib0180","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","article-title":"Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated Sepsis","volume":"25","author":"Hao","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.jsbmb.2020.105775_bib0185","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.3389\/fimmu.2018.02918","article-title":"NLRP3 inflammasome: a possible link between obesity-associated low-grade chronic inflammation and colorectal cancer development","volume":"9","author":"Ahechu","year":"2018","journal-title":"Front. Immunol."},{"issue":"4 Pt B","key":"10.1016\/j.jsbmb.2020.105775_bib0190","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.bbadis.2017.08.002","article-title":"The search for novel diagnostic and prognostic biomarkers in cholangiocarcinoma","volume":"1864","author":"Macias","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"Suppl 1","key":"10.1016\/j.jsbmb.2020.105775_bib0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/liv.14090","article-title":"Diagnostic and prognostic biomarkers in cholangiocarcinoma","volume":"39","author":"Macias","year":"2019","journal-title":"Liver Int."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076020303009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076020303009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:05:11Z","timestamp":1760745911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076020303009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":39,"alternative-id":["S0960076020303009"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105775","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of bile acid profile in plasma to differentiate cholangiocarcinoma from benign biliary diseases and healthy controls","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105775","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105775"}}